Keratosis Pilaris

Clinical guidelines for managing follicular hyperkeratosis, selecting keratolytic agents, and reviewing topical retinoid and laser therapies.

⏱️ 4 min read

Table of Contents

🧠 Standard of Care & Symptoms

Keratosis Pilaris (KP) is a very common, benign skin condition characterized by follicular hyperkeratosis, resulting in rough, small bumps typically on the outer upper arms, thighs, and cheeks.

πŸ’Š Topical & Keratolytic Agents

First-line therapy focuses on using chemical exfoliants (keratolytics) to dissolve the keratin plugs and smooth the skin's texture.

πŸ›‘οΈ Retinoids & Physical Interventions

For patients with thick, persistent bumps or significant background redness, advanced topical or procedural therapies may be indicated.

πŸ”¬ Biopsy & Histopathological Hallmarks

In the rare event a punch biopsy is performed, pathologists identify keratosis pilaris by diagnostic microscopic features focused on the hair follicle structures:

πŸ”¬ Active Clinical Trials

Clinical trials are currently evaluating high-concentration urea formulations, comparative trials between novel retinoids, and targeted laser smoothing therapies.

NCT06922299: High-Concentration Urea (20%) Cream Efficacy

A Phase III clinical trial comparing a novel 20% urea cream vs placebo in improving skin texture and reducing follicular plugs in patients with moderate-to-severe keratosis pilaris.

Key Inclusion: Age 18 to 50, clinically diagnosed moderate-to-severe keratosis pilaris on the bilateral upper arms, and willing to refrain from other chemical exfoliants.
NCT07049977: Low-Irritation Retinoid for KP Rubra

Evaluating the efficacy of a new low-irritation topical retinoid formulation in patients experiencing keratosis pilaris rubra (characterized by significant redness).

Key Inclusion: Age ≥ 18, clinically documented erythema (redness score ≥ 2) surrounding follicular plugs, and Fitzpatrick skin types I to IV.
NCT07117700: Pulsed Dye Laser and Resurfacing Laser Combination

Testing a combination Pulsed Dye Laser (PDL) and fractional resurfacing laser protocol for facial keratosis pilaris.

Key Inclusion: Moderate-to-severe facial keratosis pilaris, no history of keloid scarring, and no active sun exposure or tanning within 30 days prior.
Important: Browse actively recruiting clinical trials in our Clinical Trials Catalogue to find a local study.

πŸ—ΊοΈ Next Steps After Diagnosis

If you have recently been diagnosed with Keratosis Pilaris, follow these clinical self-care guidelines:

  1. Do Not Pick or Scrub: Avoid scrubbing the skin with harsh sponges (like loofahs) or picking at the bumps, which can lead to inflammation, infection, and permanent hyperpigmentation.
  2. Moisturize Immediately Post-Bath: Apply thick, keratolytic moisturizers (such as those containing urea or lactic acid) within 3 minutes of stepping out of the shower while the skin is damp to trap hydration.
  3. Limit Bathing Time: Take short, lukewarm showers instead of long, hot baths, which can strip the skin of its natural lipid barrier and worsen dry skin.
  4. Utilize a Humidifier: Place a humidifier in your bedroom during dry winter months to maintain ambient humidity.

❓ Patient FAQ

Q: Is keratosis pilaris curable?
A: No. KP is a genetic skin type rather than a curable disease. While treatments can highly improve skin appearance and smoothness, bumps will typically return if treatment is stopped. KP often improves naturally with age, particularly after the age of 30.

Q: Is keratosis pilaris contagious?
A: No. It is entirely a genetic disorder of skin keratin production and cannot be spread from person to person.

Get the Free 2026 Clinical AI Directory

Email us at caleb@openphr.org to receive our exclusive directory of over 150 open-source models and clinical trial databases.

Request Directory via Email